[5][6] After completing her graduate studies, Eniola-Adefeso worked in the Baylor College of Medicine as a National Institutes of Health postdoctoral fellow.

[9] In 2013, she was named a Miller Faculty Scholar at the University of Michigan and now also serves as the associate dean for graduate and professional education in the college of engineering.

Publications from her lab were the first to demonstrate that nanoparticles' size, shape, and density – acting as “vascular-targeting drug carriers (VTCs)”- matter in their ability to reach and bind the blood vessel wall.

Her critical discovery, coupled with an innovative polymer, has led to the recent formation of a startup company, Asalyxa Bio, where Eniola-Adefeso holds the chief scientific officer position.

[19] Since its incorporation in July, she has led the company to raise funds for a first-in-human clinical trial toward developing this technology to treat Acute Respiratory Distress Syndrome (ARDS).

[20] Eniola-Adefeso has been involved in the College of Engineering NextProf program, which brings women and minority students to campus to experience academic life.

The goal of the NextProf Pathfinder Workshop is to equip the attendees – mostly women and students from underrepresented groups – with the knowledge and skills needed to develop strong CVs, early in their PhD process, to make them competitive for faculty positions.